Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1979 Mar;41(3):257–262. doi: 10.1136/hrt.41.3.257

Thyroid heart disease.

C Symons
PMCID: PMC482023  PMID: 426973

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARKER S. B., LEWIS W. J. Metabolic actions of acetic acid analogs of thyroxine and triiodothyronine. Proc Soc Exp Biol Med. 1956 Apr;91(4):650–654. doi: 10.3181/00379727-91-22361. [DOI] [PubMed] [Google Scholar]
  2. BREWSTER W. R., Jr, ISAACS J. P., OSGOOD P. F., KING T. L. The hemodynamic and metabolic interrelationships in the activity of epinephrine, norepinephrine and the thyroid hormones. Circulation. 1956 Jan;13(1):1–20. doi: 10.1161/01.cir.13.1.1. [DOI] [PubMed] [Google Scholar]
  3. Bastenie P. A., Bonnyns M., Neve P., Vanhaelst L., Chailly M. Clinical and pathological significance of asymptomatic atrophic thyroiditis. A condition of latent hypothyroidism. Lancet. 1967 Apr 29;1(7496):915–918. doi: 10.1016/s0140-6736(67)91486-9. [DOI] [PubMed] [Google Scholar]
  4. Bell R., Barber P. V., Bray C. L., Beton D. C. Incidence of thyroid disease in cases of hypertrophic cardiomyopathy. Br Heart J. 1978 Nov;40(11):1306–1309. doi: 10.1136/hrt.40.11.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bernal J., Refetoff S. The action of thyroid hormone. Clin Endocrinol (Oxf) 1977 Mar;6(3):227–249. doi: 10.1111/j.1365-2265.1977.tb03319.x. [DOI] [PubMed] [Google Scholar]
  6. Buccino R. A., Spann J. F., Jr, Pool P. E., Sonnenblick E. H., Braunwald E. Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest. 1967 Oct;46(10):1669–1682. doi: 10.1172/JCI105658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bulkley B. H., Weisfeldt M. L., Hutchins G. M. Asymmetric septal hypertrophy and myocardial fiber disarray. Features of normal, developing, and malformed hearts. Circulation. 1977 Aug;56(2):292–298. doi: 10.1161/01.cir.56.2.292. [DOI] [PubMed] [Google Scholar]
  8. Burckhardt D., Staub J. J., Kraenzlin M., Raeder E., Engel U., Cloppenburg P. The systolic time intervals in thyroid dysfunction. Am Heart J. 1978 Feb;95(2):187–196. doi: 10.1016/0002-8703(78)90462-3. [DOI] [PubMed] [Google Scholar]
  9. Cohen J., Aroesty J. M., Rosenfeld M. G. Determinants of thyroxine-induced cardiac hypertrophy in mice. Circ Res. 1966 Apr;18(4):388–397. doi: 10.1161/01.res.18.4.388. [DOI] [PubMed] [Google Scholar]
  10. DeGroot L. J. Thyroid and the heart. Mayo Clin Proc. 1972 Nov;47(11):864–871. [PubMed] [Google Scholar]
  11. Fisher D. A. Thyroid function in the fetus and newborn. Med Clin North Am. 1975 Sep;59(5):1099–1107. doi: 10.1016/s0025-7125(16)31960-5. [DOI] [PubMed] [Google Scholar]
  12. Fowler P. B., Swale J., Andrews H. Hypercholesterolaemia in borderline hypothyroidism. Stage of premyxoedema. Lancet. 1970 Sep 5;2(7671):488–491. doi: 10.1016/s0140-6736(70)90111-x. [DOI] [PubMed] [Google Scholar]
  13. Fowler P. S., Swale J. Premyxoedema and coronary-artery disease. Lancet. 1967 May 20;1(7499):1077–1079. doi: 10.1016/s0140-6736(67)92650-5. [DOI] [PubMed] [Google Scholar]
  14. GRAETTINGER J. S., MUENSTER J. J., CHECCHIA C. S., GRISSOM R. L., CAMPBELL J. A. A correlation of clinical and hemodynamic studies in patients with hypothyroidism. J Clin Invest. 1958 Apr;37(4):502–510. doi: 10.1172/JCI103631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. HANSEN J. E. Paroxysmal ventricular tachycardia associated with myxedema. A case report. Am Heart J. 1961 May;61:692–697. doi: 10.1016/0002-8703(61)90643-3. [DOI] [PubMed] [Google Scholar]
  16. HOFFMAN I., LOWREY R. D. The electrocardiogram in thyrotoxicosis. Am J Cardiol. 1960 Nov;6:893–904. doi: 10.1016/0002-9149(60)90289-7. [DOI] [PubMed] [Google Scholar]
  17. Hoch F. L. Early action of injected L-thyroxine on mitochondrial oxidative phosphorylation. Proc Natl Acad Sci U S A. 1967 Aug;58(2):506–512. doi: 10.1073/pnas.58.2.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Howitt G., Rowlands D. J. The heart in hyperthyroidism. Am Heart J. 1967 Feb;73(2):282–283. doi: 10.1016/0002-8703(67)90159-7. [DOI] [PubMed] [Google Scholar]
  19. Kerber R. E., Sherman B. Echocardiographic evaluation of pericardial effusion in myxedema. Incidence and biochemical and clinical correlations. Circulation. 1975 Nov;52(5):823–827. doi: 10.1161/01.cir.52.5.823. [DOI] [PubMed] [Google Scholar]
  20. LERMAN J. Dissociation of response to triiodothyroacetic acid in myxedema: comparison with response to thyroid substance. J Clin Endocrinol Metab. 1961 Sep;21:1044–1053. doi: 10.1210/jcem-21-9-1044. [DOI] [PubMed] [Google Scholar]
  21. LIU C. T., OVERMAN R. R. EFFECT OF TOXIC DOSES OF L-THYROXINE ON TISSUE WATER, ELECTROLYTES AND PLASMA PROTEIN IN RATS. Proc Soc Exp Biol Med. 1964 Oct;117:232–236. doi: 10.3181/00379727-117-29544. [DOI] [PubMed] [Google Scholar]
  22. Langer G. A. Ion fluxes in cardiac excitation and contraction and their relation to myocardial contractility. Physiol Rev. 1968 Oct;48(4):708–757. doi: 10.1152/physrev.1968.48.4.708. [DOI] [PubMed] [Google Scholar]
  23. Levey G. S., Epstein S. E. Myocardial adenyl cyclase: activation by thyroid hormones and evidence for two adenyl cyclase systems. J Clin Invest. 1969 Sep;48(9):1663–1669. doi: 10.1172/JCI106131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nayler W. G., Merrillees N. C., Chipperfield D., Kurtz J. B. Influence of hyperthyroidism on the uptake and binding of calcium by cardiac microsomal fractions and on mitochondrial structure. Cardiovasc Res. 1971 Oct;5(4):469–482. doi: 10.1093/cvr/5.4.469. [DOI] [PubMed] [Google Scholar]
  25. Olsen E. G., Symons C., Hawkey C. Effect of triac on the developing heart. Lancet. 1977 Jul 30;2(8031):221–223. doi: 10.1016/s0140-6736(77)92836-7. [DOI] [PubMed] [Google Scholar]
  26. Page E., McCallister L. P. Quantitative electron microscopic description of heart muscle cells. Application to normal, hypertrophied and thyroxin-stimulated hearts. Am J Cardiol. 1973 Feb;31(2):172–181. doi: 10.1016/0002-9149(73)91030-8. [DOI] [PubMed] [Google Scholar]
  27. Parisi A. F., Hamilton B. P., Thomas C. N., Mazzaferri E. L. The short cardiac pre-ejection period: an index to thyrotoxicosis. Circulation. 1974 May;49(5):900–904. doi: 10.1161/01.cir.49.5.900. [DOI] [PubMed] [Google Scholar]
  28. Perloff J. K. The cardiomyopathies--current perspectives. Circulation. 1971 Nov;44(5):942–949. doi: 10.1161/01.cir.44.5.942. [DOI] [PubMed] [Google Scholar]
  29. Pietras R. J., Real M. A., Poticha G. S., Bronsky D., Waldstein S. S. Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade. Arch Intern Med. 1972 Mar;129(3):426–429. [PubMed] [Google Scholar]
  30. Resnekov L., Falicov R. E. Thyrotoxicosis and lactate-producing angina pectoris with normal coronary arteries. Br Heart J. 1977 Oct;39(10):1051–1057. doi: 10.1136/hrt.39.10.1051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. SANDLER G., WILSON G. M. The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. Q J Med. 1959 Jul;28:347–369. [PubMed] [Google Scholar]
  32. SANDLER G., WILSON G. M. The production of cardiac hypertrophy by thyroxine in the rat. Q J Exp Physiol Cogn Med Sci. 1959 Jul;44:282–289. doi: 10.1113/expphysiol.1959.sp001401. [DOI] [PubMed] [Google Scholar]
  33. SANGHVI L. M., BANERJEE K. Wolff-Parkinson-White syndrome associated with thyrotoxicosis. Am J Cardiol. 1961 Sep;8:431–437. doi: 10.1016/0002-9149(61)90164-3. [DOI] [PubMed] [Google Scholar]
  34. SOMERVILLE W., LEVINE S. A. Angina pectoris and thyrotoxicosis. Br Heart J. 1950 Jul;12(3):245–257. doi: 10.1136/hrt.12.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Staffurth J. S., Gibberd M. C., Fui S. N. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J. 1977 Sep 10;2(6088):688–690. doi: 10.1136/bmj.2.6088.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Staffurth J. S., Morrison N. D. Heart size in thyrotoxicosis. Postgrad Med J. 1968 Dec;44(518):885–890. doi: 10.1136/pgmj.44.518.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Steinberg A. D. Myxedema and coronary artery disease--a comparative autopsy study. Ann Intern Med. 1968 Feb;68(2):338–344. doi: 10.7326/0003-4819-68-2-338. [DOI] [PubMed] [Google Scholar]
  38. Stoffer S. S., Jiang N. S., Gorman C. A., Pikler G. M. Plasma catecholamines in hypothyroidism and hyperthyroidism. J Clin Endocrinol Metab. 1973 Mar;36(3):587–589. doi: 10.1210/jcem-36-3-587. [DOI] [PubMed] [Google Scholar]
  39. Symons C., Myers A., Kingstone D., Boss M. Response to thyrotrophin-releasing hormone in atrial dysrhythmias. Postgrad Med J. 1978 Oct;54(636):658–662. doi: 10.1136/pgmj.54.636.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Symons C., Olsen E. G., Hawkey C. M. The production of cardiac hypertrophy by tri-iodothyroacetic acid. J Endocrinol. 1975 Jun;65(3):341–346. doi: 10.1677/joe.0.0650341. [DOI] [PubMed] [Google Scholar]
  41. Symons C., Richardson P. J., Feizi O. Hypertrophic cardiomyopathy and hyperthyroidism: a report of three cases. Thorax. 1974 Nov;29(6):713–719. doi: 10.1136/thx.29.6.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Symons C., Richardson P. J., Wood J. B. Unusual presentation of thyrocardiac disease. Lancet. 1971 Nov 27;2(7735):1163–1167. doi: 10.1016/s0140-6736(71)90485-5. [DOI] [PubMed] [Google Scholar]
  43. Tunbridge W. M., Evered D. C., Hall R., Appleton D., Brewis M., Clark F., Evans J. G., Young E., Bird T., Smith P. A. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977 Dec;7(6):481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x. [DOI] [PubMed] [Google Scholar]
  44. UEDA H., UOZUMI Z., WATANABE H., KOBAYASHI T., KAWAI N., MATUURA T., IWASE T. PHONOCARDIOGRAPHIC STUDY OF HYPERTHYROIDISM. Jpn Heart J. 1963 Nov;4:509–523. doi: 10.1536/ihj.4.509. [DOI] [PubMed] [Google Scholar]
  45. Vanhaelst L., Neve P., Chailly P., Bastenie P. A. Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet. 1967 Oct 14;2(7520):800–802. doi: 10.1016/s0140-6736(67)92235-0. [DOI] [PubMed] [Google Scholar]
  46. Wan S. H., Lee G. S., Toh C. C. The sick sinus syndrome. A study of 15 cases. Br Heart J. 1972 Sep;34(9):942–952. doi: 10.1136/hrt.34.9.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Williams R. G., Ellison R. C., Nadas A. S. Development of left ventricular outflow obstruction in idiopathic hypertrophic subaortic stenosis. Report of a case. N Engl J Med. 1973 Apr 26;288(17):868–871. doi: 10.1056/NEJM197304262881702. [DOI] [PubMed] [Google Scholar]
  48. Zaimis E., Papadaki L., Ash A. S., Larbi E., Kakari S., Matthew M., Paradelis A. Cardiovascular effects of thyroxine. Cardiovasc Res. 1969 Apr;3(2):118–133. doi: 10.1093/cvr/3.2.118. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES